Autism Spectrum Disorder (ASD) is increasingly recognized as more than a neurodevelopmental condition. A growing body of research points to immune dysregulation, chronic inflammation, and autonomic imbalance as key biological contributors. A newly published peer reviewed study adds compelling evidence to this evolving understanding—and helps explain why mesenchymal stem cell (MSC) therapy is attracting scientific and clinical interest.
A 2024 open access publication evaluated the effects of intravenous MSC infusion on both behavioral outcomes and objective neurological activity measured through EEG. The results were consistent, measurable, and sustained.
Summary of Outcomes After IV MSC Treatment
Improved on behavioral rating scales
Improvements began
Benefits persisted
These findings reinforce what many families and clinicians have observed: when inflammation and immune imbalance are addressed, meaningful functional gains often follow.
Autism, Inflammation & the Nervous System
A large number of ASD studies have documented:
On EEG, this imbalance often appears as:
Associated with sympathetic "fight or flight" overactivation
Associated with reduced parasympathetic "rest and regulate" activity
Mesenchymal stem cells are known for their anti-inflammatory and immunomodulatory signaling, making them a promising tool for addressing these underlying biological factors—not just surface level symptoms.
Study Design: Measuring Both Behavior and Brain Function
Participants included children, adolescents, and adults with confirmed ASD diagnoses.
Behavioral Measures
- Autism Spectrum Rating Scale (ASRS)
- Parent reported global improvement assessments
Neurological Measures (EEG)
EEGs recorded before treatment and 2–3 months after infusion, focusing on:
- Cz – learning, memory, executive function
- T3 – auditory processing, language
- T4 – sensory integration, social perception
Analysis centered on:
Key Findings: Consistent Neurological & Clinical Improvement
EEG Results
Behavioral Outcomes
Exceptional Responders
Some individuals improved 55-60%
Additional Reported Gains
*In select cases
Importantly, every family reported the treatment was worthwhile, and many opted to repeat therapy.
Why EEG Data Is So Important
Behavioral improvements are meaningful—but pairing them with objective neurological changes strengthens the scientific case for MSC therapy.
This study demonstrated:
- A clear biological shift toward healthier autonomic balance
- Changes that aligned with known MSC mechanisms
- Improvements that were consistent across ages
This dual validation—clinical + neurological—is rare in autism research and represents a significant step forward.
Limitations—And Why the Findings Still Matter
The EEG subset was small, but the patterns were:
Consistent
Biologically plausible
Reproducible
Aligned with meta-analyses
In research, reproducible signals across multiple measurement types are exactly what justify larger, more rigorous trials.
What This Means for the Future of Autism Care
Traditional ASD interventions often focus on behavior alone. This study supports a broader, more integrative model:
- Treat autism as a medical condition with systemic contributors
- Address immune dysfunction and neuroinflammation
- Use objective biomarkers (like EEG) to track progress
- Follow patients longitudinally, not just short term
The BetterStem Perspective
At BetterStem, this research reinforces what we see every day in our clinical practice.
Our philosophy mirrors the study's conclusions:
- Address root biological drivers, not just behaviors
- Use advanced regenerative therapies responsibly and transparently
- Pair treatment with rigorous monitoring and objective data
- Track outcomes over time to ensure durability and accountability
This publication doesn't claim a cure—and neither do we.
What it does show is something far more meaningful: Measurable biological change paired with real world functional improvement. That's how progress happens.
Reference
"Mesenchymal Stem Cell Infusion is Consistently Effective in Improving Autism Behavioral Parameters and EEG Metrics" - Curr Neuropharmacol. 2024;22(5):844-851.
View on ResearchGateDisclaimer: This blog is for educational purposes only and does not constitute medical advice. Stem cell therapies for autism are investigational, and outcomes may vary. Families should consult qualified medical professionals to determine appropriate care options.